Cargando…

Vaccine-Induced Thrombocytopenia with Severe Headache

Detalles Bibliográficos
Autores principales:	Salih, Farid, Schönborn, Linda, Kohler, Siegfried, Franke, Christiana, Möckel, Martin, Dörner, Thomas, Bauknecht, Hans C., Pille, Christian, Graw, Jan A., Alonso, Angelika, Pelz, Johann, Schneider, Hauke, Bayas, Antonios, Christ, Monika, Kuramatsu, Joji B., Thiele, Thomas, Greinacher, Andreas, Endres, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522796/ https://www.ncbi.nlm.nih.gov/pubmed/34525282 http://dx.doi.org/10.1056/NEJMc2112974

Ejemplares similares

Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway
por: Salih, Farid, et al.
Publicado: (2022)

Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
por: Schönborn, Linda, et al.
Publicado: (2022)

Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
por: Thiele, Thomas, et al.
Publicado: (2021)

Decline in Pathogenic Antibodies over Time in VITT
por: Schönborn, Linda, et al.
Publicado: (2021)

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Greinacher, Andreas, et al.
Publicado: (2022)

Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report
por: Günther, Albrecht, et al.
Publicado: (2021)

Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)—Insights from Clinical Cases, In Vitro Studies and Murine Models
por: Dabbiru, Venkata A. S., et al.
Publicado: (2023)

SARS-CoV-2 Infection in Patients with a History of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) after SARS‐CoV‐2 vaccination: Two cases from Germany with unusual presentation
por: Edmonds, Rhea, et al.
Publicado: (2023)

Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination
por: Bayas, Antonios, et al.
Publicado: (2021)

Longitudinal Aspects of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
por: Greinacher, Andreas, et al.
Publicado: (2021)

Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021)

Large-scale cross-sectional online survey on patient-neurologist communication, burden of disease assessment and disease monitoring in people with multiple sclerosis
por: Christ, Monika, et al.
Publicado: (2023)

Risk of Blood Bag Lesions Induced by Standard Transfusion Devices
por: Raster, Johannes, et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023)

Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review
por: Warkentin, Theodore E., et al.
Publicado: (2022)

Intraarterielle Lyse verbessert funktionelles Outcome nach Thrombektomie
por: B. Kuramatsu, Joji
Publicado: (2022)

Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test
por: Hron, Gregor, et al.
Publicado: (2013)

Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature
por: Christ, Monika, et al.
Publicado: (2019)

Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
por: Graf, Tilmann, et al.
Publicado: (2021)

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination
por: Handtke, Stefan, et al.
Publicado: (2021)

Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report
por: Müller, Mona Klara Ros, et al.
Publicado: (2022)

Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials
por: Bayas, Antonios, et al.
Publicado: (2023)

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
por: Greinacher, Andreas, et al.
Publicado: (2021)

Limitations of the particle immunofiltration assay test for diagnosis of heparin‐induced thrombocytopenia
por: Warkentin, Theodore E., et al.
Publicado: (2020)

The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potential New Treatment for Vιττ
por: Vayne, Caroline, et al.
Publicado: (2021)

Hematoma expansion in intracerebral hemorrhage – the right target?
por: Haupenthal, David, et al.
Publicado: (2023)

Giant cell arteritis with vertebral artery involvement—baseline characteristics and follow-up of a monocentric patient cohort
por: Prünte, Mona Klara Ros, et al.
Publicado: (2023)

Hemostatic management of patients undergoing ear-nose-throat surgery
por: Thiele, Thomas, et al.
Publicado: (2015)

Toward the Relevance of Platelet Subpopulations for Transfusion Medicine
por: Handtke, Stefan, et al.
Publicado: (2018)

Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
por: Kuramatsu, Joji B., et al.
Publicado: (2019)

Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2
por: Thiele, Thomas, et al.
Publicado: (2021)

Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage
por: Sembill, Jochen A., et al.
Publicado: (2019)

Aneurysmatic subarachnoid haemorrhage
por: Onur, Oezguer A., et al.
Publicado: (2019)

Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
por: Bayas, Antonios, et al.
Publicado: (2015)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
por: Greinacher, Andreas, et al.
Publicado: (2022)

A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome — A Report on the Clinical Presentations of the First 100 Patients
por: Boesl, Fabian, et al.
Publicado: (2021)

Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
por: Giles, Jason B., et al.
Publicado: (2022)

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia
por: Karnes, Jason H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cpdl0f5525ali0t3d0ehc3ipcc